HSL-IN-3

CAS No. 346656-34-6

HSL-IN-3( Ethyl 2-(5,5-dimethyl-1,3,2-dioxaborinan-2-yl)benzoate | HSL inhibitor 3 )

Catalog No. M26251 CAS No. 346656-34-6

HSL-IN-3 is a boronic acid derivative that is an inhibitor of hormone-sensitive lipase(HSL).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 28 In Stock
25MG 28 In Stock
50MG 31 In Stock
100MG 45 In Stock
200MG 63 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    HSL-IN-3
  • Note
    Research use only, not for human use.
  • Brief Description
    HSL-IN-3 is a boronic acid derivative that is an inhibitor of hormone-sensitive lipase(HSL).
  • Description
    HSL-IN-3 is a boronic acid derivative that is an inhibitor of hormone-sensitive lipase(HSL).
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    Ethyl 2-(5,5-dimethyl-1,3,2-dioxaborinan-2-yl)benzoate | HSL inhibitor 3
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    PEGs
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    346656-34-6
  • Formula Weight
    262.11
  • Molecular Formula
    C14H19BO4
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 100 mg/mL (381.52 mM)
  • SMILES
    CCOC(=O)c1ccccc1B1OCC(C)(C)CO1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Snaebjornsson MT, et al. Non-canonical functions of enzymes facilitate cross-talk between cell metabolic and regulatory pathways. Exp Mol Med. 2018 Apr 16;50(4):34.
molnova catalog
related products
  • Toosendanin

    Toosendanin has effects on the growth, cell cycle arrest, induction of apoptosis and the involved signaling pathway in human promyelocytic leukemia HL-6 cells.

  • LL-37 FK-13

    LL-37 FK-13 is an antimicrobial agent, that inhibits Trichomonas vaginalis. LL-37 FK-13 exhibits slight hemolytic effects on human erythrocytes and low cytotoxicity to human fibroblasts.

  • Cyclo(Phe-Gly)

    Cyclo(Phe-Gly) shows weak antagonistic activity against VEGFR2 -CD, it also shows strong inhibitory activity against human cancer cells(KB,KBv200) with LD50 at 6.5 and 11.2 umol/L,respectively.